A subcommittee of the NCI’s Board of Scientific Advisors is considering whether to recommend that the NCI undertake a
major, randomized clinical trial to look at the incidence of mortality among
lung cancer patients who undergo a computed tomography (CT) scan.
Sullivan, associate director of the biomedical imaging program at the NCI, said
the trial could enroll as many as 20,000 patients at approximately 10 to 20
medical centers. The idea would be to determine whether tumors discovered as a
result of a "screening CT" were detected early enough to positively
affect the patient’s quality of life.
Currently, health insurance rarely pays
for a lung CT of an asymptomatic patient.